South Korea
· Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 235.09 billion. The enterprise value is 217.43 billion.
| Market Cap | 235.09B |
| Enterprise Value | 217.43B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Englewood Lab has 20.14 million shares outstanding. The number of shares has decreased by -0.83% in one year.
| Current Share Class | 20.14M |
| Shares Outstanding | 20.14M |
| Shares Change (YoY) | -0.83% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.01% |
| Owned by Institutions (%) | 2.46% |
| Float | 7.20M |
Valuation Ratios
The trailing PE ratio is 14.26 and the forward PE ratio is 13.13.
| PE Ratio | 14.26 |
| Forward PE | 13.13 |
| PS Ratio | 1.37 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 14.18 |
| P/OCF Ratio | 11.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.87, with an EV/FCF ratio of 13.12.
| EV / Earnings | 13.38 |
| EV / Sales | 1.26 |
| EV / EBITDA | 9.87 |
| EV / EBIT | 12.99 |
| EV / FCF | 13.12 |
Financial Position
The company has a current ratio of 3.03, with a Debt / Equity ratio of 0.21.
| Current Ratio | 3.03 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.36 |
| Debt / FCF | 1.81 |
| Interest Coverage | 15.38 |
Financial Efficiency
Return on equity (ROE) is 12.13% and return on invested capital (ROIC) is 6.70%.
| Return on Equity (ROE) | 12.13% |
| Return on Assets (ROA) | 5.37% |
| Return on Invested Capital (ROIC) | 6.70% |
| Return on Capital Employed (ROCE) | 10.71% |
| Revenue Per Employee | 967.23M |
| Profits Per Employee | 91.33M |
| Employee Count | 178 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 3.21 |
Taxes
In the past 12 months, Englewood Lab has paid 4.72 billion in taxes.
| Income Tax | 4.72B |
| Effective Tax Rate | 22.52% |
Stock Price Statistics
The stock price has decreased by -50.50% in the last 52 weeks. The beta is 0.47, so Englewood Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -50.50% |
| 50-Day Moving Average | 10,882.00 |
| 200-Day Moving Average | 9,570.90 |
| Relative Strength Index (RSI) | 53.26 |
| Average Volume (20 Days) | 320,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 172.17 billion and earned 16.26 billion in profits. Earnings per share was 818.20.
| Revenue | 172.17B |
| Gross Profit | 36.80B |
| Operating Income | 16.74B |
| Pretax Income | 20.98B |
| Net Income | 16.26B |
| EBITDA | 22.04B |
| EBIT | 16.74B |
| Earnings Per Share (EPS) | 818.20 |
Balance Sheet
The company has 47.69 billion in cash and 30.03 billion in debt, giving a net cash position of 17.66 billion or 876.82 per share.
| Cash & Cash Equivalents | 47.69B |
| Total Debt | 30.03B |
| Net Cash | 17.66B |
| Net Cash Per Share | 876.82 |
| Equity (Book Value) | 144.81B |
| Book Value Per Share | 7,288.73 |
| Working Capital | 104.58B |
Cash Flow
In the last 12 months, operating cash flow was 20.74 billion and capital expenditures -4.16 billion, giving a free cash flow of 16.58 billion.
| Operating Cash Flow | 20.74B |
| Capital Expenditures | -4.16B |
| Free Cash Flow | 16.58B |
| FCF Per Share | 822.87 |
Margins
Gross margin is 21.37%, with operating and profit margins of 9.73% and 9.44%.
| Gross Margin | 21.37% |
| Operating Margin | 9.73% |
| Pretax Margin | 12.19% |
| Profit Margin | 9.44% |
| EBITDA Margin | 12.80% |
| EBIT Margin | 9.73% |
| FCF Margin | 9.63% |
Dividends & Yields
This stock pays an annual dividend of 103.00, which amounts to a dividend yield of 0.89%.
| Dividend Per Share | 103.00 |
| Dividend Yield | 0.89% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 13.47% |
| Buyback Yield | 0.83% |
| Shareholder Yield | 1.72% |
| Earnings Yield | 6.91% |
| FCF Yield | 7.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 4.62 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.62 |
| Piotroski F-Score | 6 |